Match tier Likely match
Presence Current · Arkansas
Last published 2022
Sources OpenAlex · ORCID
Refreshed 2026-10-08

Brad Baltz

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

Also affiliated: Merck & Co., Inc., Rahway, NJ, USA (United States) (2019); Cleveland Clinic (2007); University of Tennessee Health Science Center (2014); University Hospitals of Cleveland (2007); Juravinski Cancer Centre (2007); Catholic Health Initiatives (2022); University of Chicago Medical Center (2007); Piedmont Cancer Institute (2007); Lady of Mercy Medical Center (2007); CHI St. Vincent (2021); Nuvance Health (2022)

5 h-index 9 pubs 90 cited

  • Humans
  • Herpes Zoster Vaccine
  • Multiple Sclerosis
  • Lymphoma, B-Cell
  • Multiple Sclerosis, Relapsing-Remitting
  • Injection Site Reaction
  • Aged
  • Antineoplastic Agents
  • Double-Blind Method
  • Female
  • Herpes Zoster
  • Male
  • Middle Aged
  • Neoplasms
  • Vaccination

Biography and Research Information

OverviewAI-generated summary

Brad Baltz's research has focused on clinical outcomes and treatment efficacy across various patient populations. He has investigated the safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies, contributing to a randomized, double-blind, phase 3 trial. Baltz has also examined the use of sorafenib in the management of advanced renal cell carcinoma, including a subset analysis of patients with brain metastases. His work includes studies on sickle cell disease, with publications detailing baseline characteristics and clinical outcomes from long-term, prospective registry trials. Additionally, Baltz has reported on a case of primary mediastinal large B-cell lymphoma in a patient undergoing treatment for multiple sclerosis and investigated pembrolizumab-induced myocarditis and polyradiculoneuropathy.

Metrics

  • h-index: 5
  • Publications: 9
  • Citations: 90

Selected Publications

  • Pembrolizumab-Induced Myocarditis and Delayed Acute Inflammatory Demyelinating Polyradiculoneuropathy (2022)
    Cureus 4 citations DOI OpenAlex
  • Primary mediastinal large B-cell lymphoma in a patient on Fingolimod for relapsing-remitting multiple sclerosis (2021)
    Multiple Sclerosis and Related Disorders 7 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

7 Collaborators 6 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics